Jitendra Wadhane - 15 Nov 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Issuer symbol
PYXS
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 16:16:45 UTC
Previous filing
27 Sep 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +40,000 +18% $0.000000 266,937 15 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on November 14, 2024, subject to the Reporting Person's continued employment through the vesting date.